Health Trials

APAC - Acute Primary Angle Closure

1

Review clinical trials related to APAC - Acute Primary Angle Closure. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Clinical Study of FB1001 in Patients

This study is designed for single-center, open-label, dose escalation phase I trial to evaluate the safety and tolerability of a single/multiple intravitreal injection of FB1001 in patients with APACG(Acute Primary Angle-Closure Glaucoma) or NAION(Nonarteritic Anterior Ischemic Optic Neuropathy).

Participants needed: 59
Trial details
Phase: Phase 1Age: 40+Biological sex: AllType: InterventionalSponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineUpdated: Jul 17, 2024Locations: 1
Eligibility criteria

Patients with Acute Primary Angle-Closure Glaucoma (APACG) Optic Neuropathy： [+11]

History or current diagnosis of glaucoma in both eyes; [+34]

Read more